ORF Biologics specializes in growth factors, fusion proteins, and antibodies produced using CHO, HEK, Pichia, Bacillus, and E. Coli. These biologics target high-impact applications such as wound healing, cancer, neuroscience and immunology, and often aren’t available anywhere else.

With a proprietary “plug-and-play” expression platform, we rapidly develop novel therapeutics from gene to final product, providing full concept-to-commercialization services. Our expertise extends to pharmaceutical-scale manufacturing and disruptive, patentable technologies not available from typical providers.